MAPT and Alzheimer disease: Insulin resistance has been repeatedly considered a direct causal factor for AD development, since a down-regulation in insulin signaling and a concomitant activation of stress kinases such as c-Jun-n-terminal kinases (JNK) are known to contribute to Aβ deposition and tau phosphorylation, followed by accumulation of NFT in the brain [24,25].